<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for DXS - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/dxs/dxs000.html</link>
    <description>DXS news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Fri, 05 Sep 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Fri, 05 Sep 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>DXS signs agreement with Wellcome Trust</title>
      <description>DXS has signed a non-exclusive global licensing agreement with the Wellcome Trust to expand its range of companion diagnostics.</description>
      <pubDate>Thu, 04 Sep 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs116.html</link>
    </item>
    <item>
      <title>DXS appoints diagnostics product manager</title>
      <description>DXS, the personalised medicine company, has announced the appointment of Vicki Wilson as diagnostics product manager. </description>
      <pubDate>Wed, 27 Aug 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs115.html</link>
    </item>
    <item>
      <title>DxS launches mutation kit for K-Ras in Australia</title>
      <description>TheraScreen K-Ras kit allows clinicians to screen patients for mutations in the K-Ras gene, which correlates with poor prognosis if patients are treated with a class of drugs called EGFR inhibitors</description>
      <pubDate>Wed, 02 Jul 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs114.html</link>
    </item>
    <item>
      <title>Deal with Roche for K-RAS and EGFR cancer tests</title>
      <description>Roche and DxS have signed an exclusive distribution agreement for the DxS TheraScreen K-RAS mutation test and TheraScreen EGFR 29 mutation test</description>
      <pubDate>Tue, 03 Jun 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs113.html</link>
    </item>
    <item>
      <title>DxS plans to expand manufacturing capacity</title>
      <description>DxS will take on more specialised manufacturing space at its current site in Manchester, and intends to have doubled in size over the coming months</description>
      <pubDate>Mon, 26 May 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs112.html</link>
    </item>
    <item>
      <title>Genzyme announces sublicense agreement with DxS</title>
      <description>The license permits DxS to commercialise diagnostic and research products that detect mutations in the kinase domain of the EGFR gene</description>
      <pubDate>Thu, 21 Feb 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs111.html</link>
    </item>
    <item>
      <title>Securing Scorpions technology for R+D use</title>
      <description>DxS and Epigenomics enter into cross-licensing agreement for the use of Scorpions technology in DNA methylation based testing</description>
      <pubDate>Tue, 15 Jan 2008 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs110.html</link>
    </item>
    <item>
      <title>Kit used to assess tumour mutation status</title>
      <description>DxS K-Ras mutation detection kit used to assess tumour mutation status prior to treatment with Amgen's Vectibix</description>
      <pubDate>Thu, 27 Sep 2007 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs109.html</link>
    </item>
    <item>
      <title>Assay detects V600E mutation in the B-RAF oncogene</title>
      <description>The DxS B-RAF assay detects V600E, the most common mutation in the B-RAF oncogene, which occurs in many types of cancer including melanoma, colorectal and lung</description>
      <pubDate>Tue, 18 Sep 2007 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs108.html</link>
    </item>
    <item>
      <title>Biotechnology award from BioNow for cancer product</title>
      <description>DxS has won a coveted 'Biotechnology Project of the Year' award for its highly sensitive EGFR (epidermal growth factor receptor) mutation test kit</description>
      <pubDate>Thu, 30 Nov 2006 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs107.html</link>
    </item>
    <item>
      <title>Clinical pharmacology collaboration</title>
      <description>DxS, a personalised medicine company, will assist the AstraZeneca research fellow at University of Manchester in the development of mutation detection assays using its Scorpions and Arms technologies</description>
      <pubDate>Tue, 08 Aug 2006 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs106.html</link>
    </item>
    <item>
      <title>New mutation test kit from DxS</title>
      <description>Improving the detection of T790M mutations on the EGFR gene Lung cancer patients using a new mutation test kit from DxS.</description>
      <pubDate>Wed, 26 Jul 2006 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs105.html</link>
    </item>
    <item>
      <title>EGFR mutation could lead to less invasive testing</title>
      <description>Superior performance of EGFR mutation test kit creates scope for blood-based prediction of drug response in lung cancer, according to a paper in Clinical Cancer Research</description>
      <pubDate>Wed, 12 Jul 2006 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs104.html</link>
    </item>
    <item>
      <title>Brothers in Arms win licence extension</title>
      <description>Amplification refractory mutation system technology (Arms) is a well-established and reliable method for the detection of genetic variations and single nucleotide polymorphisms (SNPs)</description>
      <pubDate>Tue, 10 Jan 2006 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs103.html</link>
    </item>
    <item>
      <title>Human IVD extension of probe licence</title>
      <description>Probes are highly sensitive, sequence-specific, bi-functional molecules containing a PCR primer covalently linked to a probe</description>
      <pubDate>Tue, 06 Dec 2005 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs102.html</link>
    </item>
    <item>
      <title>UK Biobank invests in genetic expertise</title>
      <description>Pilot study confirms that collection and transport of volunteer's blood from sites around the UK to the Biobank laboratories in Manchester could be undertaken without any reduction in sample quality</description>
      <pubDate>Wed, 14 Sep 2005 08:00:00 UT</pubDate>
      <category>DXS</category>
      <link>http://www.laboratorytalk.com/news/dxs/dxs101.html</link>
    </item>
  </channel>
</rss>
